IL36G and type 2 diabetes mellitus: These elevated levels were observed among obese patients irrespective of whether they exhibited evidence of type 2 diabetes (i.e. HbA1c ≥ 48 mmol/mol), indicating that elevated IL-36γ expression is directly associated with the obese phenotype.